Group One Trading’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-42,300
| Closed | -$178K | – | 8528 |
|
|
2023
Q1 | $178K | Buy |
42,300
+36,600
| +642% | +$190K | ﹤0.01% | 3781 |
|
|
2022
Q4 | $34.3K | Sell |
5,700
-17,800
| -76% | -$97.1K | ﹤0.01% | 5249 |
|
|
2022
Q3 | $137K | Sell |
23,500
-197,500
| -89% | -$1.23M | ﹤0.01% | 4492 |
|
|
2022
Q2 | $1.32M | Buy |
221,000
+196,800
| +813% | +$1.01M | ﹤0.01% | 2470 |
|
|
2022
Q1 | $113K | Buy |
24,200
+19,000
| +365% | +$56.7K | ﹤0.01% | 5376 |
|
|
2021
Q4 | $13K | Sell |
5,200
-19,300
| -79% | -$47.2K | ﹤0.01% | 7255 |
|
|
2021
Q3 | $72K | Sell |
24,500
-2,800
| -10% | -$7.63K | ﹤0.01% | 6238 |
|
|
2021
Q2 | $68K | Sell |
27,300
-6,300
| -19% | -$15.1K | ﹤0.01% | 6320 |
|
|
2021
Q1 | $98K | Buy |
33,600
+33,300
| +11,100% | +$109K | ﹤0.01% | 5688 |
|
|
2020
Q4 | $1K | Buy |
+300
| New | +$998 | ﹤0.01% | 6393 |
|
|
2016
Q1 | – | Sell |
-600
| Closed | -$7K | – | 5498 |
|
|
2015
Q4 | $7K | Sell |
600
-220
| -27% | -$2.94K | ﹤0.01% | 4310 |
|
|
2015
Q3 | $12K | Buy |
820
+220
| +37% | +$3.8K | ﹤0.01% | 4255 |
|
|
2015
Q2 | $12K | Sell |
600
-13,100
| -96% | -$253K | ﹤0.01% | 4252 |
|
|
2015
Q1 | $248K | Buy |
13,700
+11,080
| +423% | +$249K | ﹤0.01% | 2212 |
|
|
2014
Q4 | $62K | Buy |
2,620
+2,210
| +539% | +$51.1K | ﹤0.01% | 3221 |
|
|
2014
Q3 | $10K | Sell |
410
-6,270
| -94% | -$163K | ﹤0.01% | 4490 |
|
|
2014
Q2 | $188K | Sell |
6,680
-38,320
| -85% | -$1.15M | ﹤0.01% | 2469 |
|
|
2014
Q1 | $1.53M | Buy |
45,000
+28,860
| +179% | +$986K | 0.03% | 788 |
|
|
2013
Q4 | $310K | Buy |
16,140
+4,970
| +44% | +$90.5K | ﹤0.01% | 2047 |
|
|
2013
Q3 | $183K | Buy |
11,170
+10,740
| +2,498% | +$124K | ﹤0.01% | 2462 |
|
|
2013
Q2 | $5K | Buy |
+430
| New | +$5.04K | ﹤0.01% | 4725 |
|
Other funds holding CTIC
Group One Trading's CTIC Position: Q2 2023 in Review
Group One Trading sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 16,573 shares — an estimated $69.6K sold.
Group One Trading first reported a position in CTIC in Q2 2013 and held it in 24 quarters. The position peaked at $970K in Q2 2022. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.
- Group One Trading reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
- Group One Trading sold 16,573 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $69.6K.
- Group One Trading first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2013 and held it in 24 quarters.
- Group One Trading's CTI BioPharma Corp. (DE) Common Stock position peaked at $970K in Q2 2022.
- 2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.
Based on Group One Trading's 13F filing for Q2 2023, filed 9 Aug 2023.